Context, consent, and continuity: Strengthening dementia diagnosis communication
Filipe Prazeres

Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsPatient-Provider Communication in Healthcare · Healthcare Decision-Making and Restraints · Dementia and Cognitive Impairment Research
1
Dear Editor
The study by Singh Solorzano and colleagues1 on the psychological impact of revealing a diagnosis of Alzheimer's disease (AD) provides evidence that this event is far from a neutral one. Their finding that nearly half of the studied caregivers developed moderate‐to‐severe post‐traumatic stress symptoms (PTSSs), often persisting for years, underscores the lasting weight of disclosure on caregiver well‐being.1 In light of these results, I would like to highlight, from my perspective as a family physician, several aspects of medical communication that deserve closer attention.
First, the characteristics of the space in which disclosure occurred were not directly assessed. Family physicians interact with patients in different health care environments, ranging from their offices to the patient's home and, increasingly, through online platforms,2 and since the setting can influence the doctor–patient interaction,3 it is important to choose a quiet, private, and well‐lit space and allow enough time for the conversation without external interruptions. In daily practice, we often find ourselves without enough time to dedicate to our patients because of the many tasks at hand. However, for a patient who receives an AD diagnosis, it is essential to show sensitivity to the emotional weight of the diagnosis, a component emphasized in recent guidance,4 which, in my experience, cannot be addressed in haste. Singh Solorzano et al.1 showed how vividly disclosure moments are remembered, often with intrusive thoughts years later. This raises the question: might the setting itself influence whether disclosure is experienced as traumatic?
Second, the study of Singh Solorzano and colleagues1 highlights the Italian context, where diagnoses are often disclosed primarily to caregivers.1 This practice, although intended to protect patients, may explain the high levels of distress observed among caregivers. Broader recommendations stress the involvement of both patient and care partner,4 but often without clarifying that such involvement must depend on the patient's wishes. Informed, clear, and voluntary consent is a complex issue in persons living with dementia, particularly in stages where they are no longer able to provide free and informed consent.5 In these cases, the intervention of a legal representative or court‐appointed guardian is required. The findings of Singh Solorzano and colleagues1 remind us that excluding the patient can both undermine autonomy and overload caregivers with responsibility, thereby transforming disclosure into a traumatic event rather than a shared understanding. It is also worth noting that Singh Solorzano et al.1 focused on AD disclosure, whereas recent guidance also extends to mild cognitive impairment (MCI).4 In MCI, individuals typically retain greater decision‐making capacity, making respect for autonomy and consent even more critical.
Third, Singh Solorzano et al.1 concluded that empathic communication and psychological counseling should accompany disclosure,1 a crucial step. Yet their results also highlight the need for structured medical follow‐ups and access to community support services, which play a crucial role in helping people with dementia and their careers maintain well‐being and deal with the challenges of the illness,6 beyond the initial diagnosis. Although recent guidance has focused on the content of disclosure itself,^2^ the persistence of PTSSs in the Singh Solorzano et al.1 study alerts to the risks of leaving families without sustained support after the conversation ends. As family physicians, we often overlook these aspects, but we should not, for the sake of our patients.
Taken together, these observations emphasize that effective communication of an AD diagnosis requires more than clarity and sensitivity in language. It also requires attention to the place where disclosure occurs, whose choices guide involvement, and what services are in place for continuity of care. By integrating these dimensions, physicians may reduce the risk that disclosure becomes a source of enduring trauma and instead make it a constructive step toward shared care planning with the patient, physician, and care partner.
CONFLICT OF INTEREST STATEMENT
The author has no conflicts of interest to declare. Author disclosures are available in the Supporting Information.
Supporting information
Supporting Information
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Singh Solorzano C , Bonomini C , Rosini S , et al. The psychological impact of the disclosure of the diagnosis of Alzheimer's disease on informal caregivers. Alzheimers Dement. 2025;21:e 70412. doi:10.1002/alz.70412 40908671 10.1002/alz.70412 PMC 12411668 · doi ↗ · pubmed ↗
- 2Prazeres F , Jamoulle M , Kareli A , et al. Delphi definition of general practice/family medicine specialty for a post‐COVID world: in‐person and remote care delivery. Fam Pract. 2025;42:cmae 061. doi:10.1093/fampra/cmae 061 39561247 10.1093/fampra/cmae 061 · doi ↗ · pubmed ↗
- 3Okken V , van Rompay T , Pruyn A . Exploring space in the consultation room: environmental influences during patient‐physician interaction. J Health Commun. 2012;17:397‐412. doi:10.1080/10810730.2011.626498 22150080 10.1080/10810730.2011.626498 · doi ↗ · pubmed ↗
- 4O'Brien K , Largent EA , Karlawish J . Communicating a diagnosis of mild cognitive impairment or dementia. JAMA. 2025;334:1014‐1015. doi:10.1001/jama.2025.13006 40736397 10.1001/jama.2025.13006 PMC 12514450 · doi ↗ · pubmed ↗
- 5Parmar D . Ethical aspects of informed consent in dementia. Glob Bioeth Enq. 2021;9:42‐45. doi:10.38020/gbe.9.1.2021.42‐45
- 6Pepper A , Dening KH . Community support for families affected by dementia. Br J Community Nurs. 2024;29:218‐223. doi:10.12968/bjcn.2024.29.5.218 38701008 10.12968/bjcn.2024.29.5.218 · doi ↗ · pubmed ↗
